Racial Politics Threaten Medical Excellence at UCLA School of Medicine

Future doctors were selected through a system built on racial discrimination, the Justice Department found May 6. UCLA's David Geffen School of Medicine ignored a Supreme Court ban on race-based admissions and deliberately discriminated against applicants by race, according to a damning federal investigation. The probe revealed a campus culture where administrators used intimidation to enforce racial preferences. The findings raise urgent questions about patient safety when medical schools prioritize identity politics over academic merit.

The Justice Department's year-long investigation exposed a pattern of racial discrimination across the 2023, 2024, and 2025 incoming classes. UCLA employed racial proxies and pressure tactics to continue practices the Supreme Court banned in its Students for Fair Admissions v. Harvard decision. This deliberate circumvention of civil rights law represents a fundamental threat to medical excellence and public health standards.

Statistical evidence reveals substantial academic disparities between admitted racial groups at UCLA. In the 2024 class, admitted Black students posted a median GPA of 3.72 and MCAT scores at the 72nd percentile, while Hispanic students posted a median GPA of 3.56 with scores at the 66th percentile. White students showed a 3.83 GPA with 86th percentile MCATs, and Asian students achieved a 3.84 GPA at the 90th percentile. The DOJ noted these gaps represent approximately one standard deviation in academic preparedness.

Internal documents obtained by investigators show UCLA admissions leadership developed systematic workarounds to maintain diversity goals despite the legal ban. Executive Director of Admissions Alisa Lopez distributed an Association of American Medical Colleges document outlining workarounds to achieve diversity targets. A "Guiding Principles for Student Representation" memo instructed committee chairs to ensure BIPOC representation through 2024.

Associate Dean of Admissions Jennifer Lucero allegedly used intimidation and shaming tactics to pressure committee members into unlawfully considering race. She reportedly forced them to sit through a two-hour lecture delivered by her sister. A secondary application used in 2024 and 2025 asked applicants whether they identified as part of a marginalized group. The DOJ said the technique was designed to elicit racial disclosure for discriminatory purposes.

The human cost of these policies emerges in troubling performance data. A whistleblower reported that 50 percent of UCLA medical students failed standardized clinical exams at the end of rotations, compared to a 5 percent national failure rate. Faculty members noticed a sharp decline in student knowledge and preparedness. "I don't know how some of these students are going to be junior doctors," the whistleblower told the Washington Examiner.

Assistant Attorney General Harmeet K. Dhillon condemned UCLA's conduct at a May 6 press conference. "UCLA's admissions process has been focused on racial demographics at the expense of merit and excellence — allowing racial politics to distract the school from the vital work of training great doctors," Dhillon stated. "Racism in admissions is both illegal and anti-American, and this Department will not allow it to continue."

First Assistant U.S. Attorney Bill Essayli echoed the condemnation. "Federal law and the Supreme Court precedent are clear: Race discrimination has no place in our nation's institutions of higher learning," Essayli said. "The pattern of illegal and odious conduct by UCLA's medical school is abhorrent to our Constitution and our nation's founding principles."

The UCLA case represents just one front in a broader federal enforcement push against identity politics in medical education. The Trump administration has opened parallel investigations at Stanford, Ohio State, and UC San Diego medical schools. The Liaison Committee on Medical Education rescinded diversity requirements and the Accreditation Council for Graduate Medical Education suspended others after President Trump signed an executive order threatening to revoke accreditors' certification for institutions maintaining such mandates.

UCLA officials issued a flat denial of the allegations. "The admissions process at David Geffen School of Medicine at UCLA is based on merit and grounded in a rigorous, comprehensive review of each applicant," a spokesperson stated. "We are confident in our practices and our mission to maintain access to a high-quality education to all qualified students."

Critics of the DOJ's approach questioned the department's interpretation of the law. "They probably have their vision of what they think compliance with SFFA is, but that's not what SFFA actually says," said Julie Park, a professor of education at the University of Maryland.

James Murphy, a senior fellow at Class Action, called the evidence "really weak" and labeled the investigation "a case of absolute gross government overreach." Murphy noted the DOJ letter included few references to institutional documents or interviews with UCLA employees and students, which he said are standard in civil rights investigations.

Kristina Rasmussen, executive director of the medical advocacy group Do No Harm, praised the Justice Department's involvement in the case her organization helped initiate. "The United States was right in its move to join this case, which is of great public importance," Rasmussen said. "We look forward to the Justice Department's additional efforts here to get to the bottom of what appears to be an effort by UCLA to continue a race-based medical school admissions process in contravention of the Constitution and the Supreme Court's decision in Students for Fair Admissions."

UCLA receives direct federal financial assistance totaling $1,992,200 under two specific grants, giving the Justice Department leverage to seek enforcement through potential funding cuts if the school fails to reach a voluntary resolution. The DOJ's findings letter explicitly states the school violated Title VI of the Civil Rights Act of 1964, which prohibits discrimination in federally funded programs.

The ongoing investigations and the DOJ's voluntary resolution push signal a sustained federal challenge to identity politics in medical education. The UCLA case underscores the fundamental tension between diversity mandates and merit-based standards that protect both academic excellence and patient safety, with implications that extend far beyond one campus to the future of medical training nationwide.